Strimvelis

DB17594InvestigationalCell transplant therapies

Strimvelis: Overview.

Mechanism: Pharmacologically active on Adenosine deaminase
Curator reviewed
Also known as: Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence · GSK 2696273 · GSK-2696273

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Strimvelis, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.